Xi'an International Medical Investment Company Limited - Laporan Laba Rugi (TTM)

Xi'an International Medical Investment Company Limited
CN ˙ SZSE
CN¥ 5.15 ↑0.01 (0.19%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Xi'an International Medical Investment Company Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,391 1,607 1,964 2,273 2,583 2,921 2,594 2,683 2,786 2,711 3,465 3,853 4,141 4,618 4,732 4,829 4,880 4,815 4,640 4,429
Change (%) 15.56 22.22 15.74 13.64 13.08 -11.21 3.43 3.86 -2.71 27.82 11.18 7.48 11.52 2.47 2.05 1.08 -1.33 -3.65 -4.53
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,536 1,764 1,999 2,273 2,523 2,891 2,855 2,926 3,051 2,913 3,341 3,691 3,860 4,200 4,308 4,356 4,426 4,389 4,253 4,059
Change (%) 14.87 13.31 13.72 10.97 14.60 -1.26 2.51 4.28 -4.55 14.73 10.45 4.60 8.79 2.59 1.11 1.61 -0.84 -3.10 -4.56
% of Revenue 110.43 109.77 101.77 99.99 97.65 98.97 110.05 109.07 109.51 107.44 96.43 95.79 93.23 90.94 91.05 90.21 90.69 91.15 91.67 91.65
Gross Operating Profit -145 -157 -35 0 61 30 -261 -243 -265 -202 124 162 280 418 423 473 454 426 386 370
Change (%) 8.28 -77.86 -100.52 33,769.26 -50.18 -962.83 -6.69 8.84 -23.90 -161.39 31.03 72.94 49.15 1.25 11.62 -3.89 -6.16 -9.38 -4.21
% of Revenue -10.43 -9.77 -1.77 0.01 2.35 1.03 -10.05 -9.07 -9.51 -7.44 3.57 4.21 6.77 9.06 8.95 9.79 9.31 8.85 8.33 8.35
SG&A 460 458 485 545 635 663 664 669 647 640 656 663 660 662 663 632 630 554 549 560
Change (%) -0.39 5.85 12.34 16.40 4.42 0.27 0.68 -3.22 -1.21 2.59 1.01 -0.40 0.34 0.10 -4.63 -0.45 -12.03 -0.96 2.05
% of Revenue 33.10 28.53 24.71 23.98 24.57 22.69 25.62 24.94 23.23 23.59 18.94 17.20 15.94 14.34 14.01 13.10 12.90 11.50 11.82 12.64
R&D 9 10 10 11 12 13 13 14 15 16 16 17 16 10 8 7 6 7 7 7
Change (%) 5.90 1.49 10.08 7.59 9.84 -1.84 13.26 3.62 5.24 6.23 1.08 -6.41 -37.07 -14.08 -21.28 -9.69 16.64 0.80 -0.54
% of Revenue 0.66 0.60 0.50 0.48 0.45 0.44 0.48 0.53 0.53 0.57 0.48 0.43 0.38 0.21 0.18 0.14 0.12 0.15 0.15 0.16
OpEx 2,011 2,248 2,509 2,850 3,200 3,595 3,564 3,636 3,742 3,606 4,063 4,436 4,610 4,941 5,047 5,059 5,109 5,012 4,873 4,688
Change (%) 11.79 11.61 13.60 12.28 12.34 -0.85 2.02 2.90 -3.62 12.66 9.17 3.94 7.17 2.15 0.24 0.99 -1.90 -2.77 -3.79
% of Revenue 144.60 139.89 127.74 125.38 123.88 123.07 137.42 135.55 134.29 133.02 117.25 115.13 111.34 106.99 106.66 104.77 104.68 104.07 105.03 105.85
Operating Income -620 -641 -545 -577 -617 -674 -971 -954 -955 -895 -598 -583 -470 -323 -315 -230 -228 -196 -233 -259
Change (%) 3.34 -15.00 5.88 6.92 9.26 44.05 -1.76 0.19 -6.29 -33.24 -2.48 -19.45 -31.26 -2.42 -26.94 -0.80 -14.09 18.95 11.03
% of Revenue -44.60 -39.89 -27.74 -25.38 -23.88 -23.07 -37.42 -35.55 -34.29 -33.03 -17.25 -15.13 -11.34 -6.99 -6.66 -4.77 -4.68 -4.07 -5.03 -5.85
Interest Expense -155 -154 -160 -169 -180 -191 -197 -199 -197 -191 -197 -214 -223 -219 -215 -196 -220 -173 -165 -157
Change (%) -0.53 4.20 5.46 6.32 6.01 3.09 0.98 -0.64 -3.44 3.63 8.51 4.31 -1.99 -1.86 -8.80 12.15 -21.15 -4.66 -4.85
% of Revenue -11.14 -9.58 -8.17 -7.45 -6.97 -6.53 -7.58 -7.40 -7.08 -7.03 -5.70 -5.56 -5.40 -4.74 -4.54 -4.06 -4.50 -3.60 -3.56 -3.55
Net Income -882 45 52 30 -41 -822 -1,068 -1,058 -1,064 -1,177 -823 -803 -572 -368 -399 -320 -358 -254 -256 -245
Change (%) -105.14 14.00 -42.90 -239.34 1,898.26 29.84 -0.89 0.60 10.56 -30.06 -2.40 -28.80 -35.59 8.19 -19.78 12.02 -29.04 0.57 -3.95
% of Revenue -63.43 2.82 2.63 1.30 -1.59 -28.15 -41.16 -39.44 -38.20 -43.40 -23.75 -20.85 -13.81 -7.98 -8.42 -6.62 -7.34 -5.28 -5.51 -5.54

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista